Director, BD - M&A and Divestments

Dr. Reddy’s Laboratories Ltd. is a leading multinational pharmaceutical company based across global locations. Each of our 24,000 plus employees comes to work every day for one collective purpose: to accelerate access to affordable and innovative medicines because Good Health Can’t Wait.

We started in 1984 with a modest investment, 20 employees and a bold vision. Today, we have research and development centres, manufacturing facilities or a commercial presence in 66 countries.

For nearly four decades, we have stood for access, affordability and innovation based on the bedrock of deep science, progressive people practices and robust corporate governance. As the pharmaceutical industry evolves and undergoes disruption, we see an opportunity – to strengthen our core further (the next steps) and to build the future (the new bets).

‘The Next and the New’ is how we aim to continue to be the partner of choice – purpose-driven, future-ready and sustainable. Our aim is to reach over 1.5 Bn+ patients across the world by 2030 by growing our core businesses and building for the future with sustainability at the core of our purpose and strategy. Sustainability for us means operating in a manner that respects people, planet and purpose – helping us conserve precious resources, serve our patients, create value for stakeholders, give back to society, fulfil our potential and maintain our integrity and transparency

Dr Reddy’s maintains a work environment, free from discrimination and is an equal opportunity employer. We are committed to employ & nurture all qualified diverse workforce without regard to race, colour religion, nationality, sex, age, disability status, genetics, sexual orientation, gender expression, citizenship or any other characteristic or classification protected by applicable law(s) of the country we operate in. We treasure every talent, and recognize merit and diversity in our organization.

The Director, BD – M&A and Divestments is responsible for driving Dr. Reddy’s inorganic growth agenda in the India market by identifying, evaluating, and executing high‑impact M&A opportunities across brands, portfolios, novel technologies, companies, and strategic alliances, while also maximizing value through the divestment of non‑core assets in line with the organization’s strategic priorities. The role leads end‑to‑end deal processes—including opportunity screening, commercial and financial analysis, valuation, due diligence, risk assessment, negotiation, and closure—and ensures seamless post‑transaction integration and transition support. It also involves developing strategic alliances by building senior‑level relationships, aligning internal stakeholders, structuring mutually beneficial partnership models, and managing cross‑functional diligence and contract negotiations. The position requires strong business acumen, financial modelling knowledge, understanding of regulatory, medical, quality, commercial, and supply chain concepts, and the ability to collaborate effectively within a matrix organization. 

MBA or CA with 6–10 years of experience in M&A within the Pharma sector or in Consulting firms, with strong and proven experience in executing M&A deals and the ability to confidently represent the organization in front of bankers, investors, advisors, and C‑suite level internal and external stakeholders.